Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
IMPEL PHARMACEUTICALS INC (IMPL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Credit agreement amendment
Docs: "OAKTREE FUND ADMINISTRATION, LLC By: Oaktree Capital Management, L.P. Its: Managing Member"
08/21/2023 8-K Credit agreement amendment
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/12/2023 8-K Quarterly results
Docs: "IMPEL PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor Conference Call Today at 8:30 a.m. ET"
05/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/17/2023 8-K Quarterly results
03/24/2023 8-K Quarterly results
Docs: "IMPEL PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Trudhesa® Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in Q4 vs. Q3 2022 to $5 Million Impel to Host Investor Conference Call Today at 8:30 a.m. ET"
01/09/2023 8-K Quarterly results
11/14/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
05/25/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/26/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF IMPEL NEUROPHARMA, INC. Impel NeuroPharma, Inc., a Delaware corporation , does hereby certify that the following amendment to the corporation’s Restated Certificate of Incorporation has been duly adopted in accordance with the provisions of Section 242 of the Delaware General Corporation Law. FIRST: The Corporation was incorporated pursuant to the General Corporation Law on July 24, 2008. The following amendment to the Restated Certificate of Incorporation, filed with the Delaware Secretary of State on April 27, 2021 has been duly adopted in accordance with the provisions of Section 242 of the Delaware General Corporation Law. SECOND: Article I of the Restated Certificate of Incorporation, relating to the name of the corp..."
04/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SIMILAR PK TO OLANZAPINE INJECTION, BUT FASTER TO PEAK BLOOD LEVELS"
03/24/2022 8-K Quarterly results
Docs: "IMPEL NEUROPHARMA, INC."
03/17/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
01/18/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Melyssa Weible Elixir Health Public Relations Phone:",
"250 482 632 250 482 632"
11/15/2021 8-K Quarterly results
Docs: "Christina Tartaglia Stern Investor Relations Phone:"
10/01/2021 8-K Quarterly results
07/07/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "# # #"
06/07/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy